Clopidogrel in Orthopaedic patients: a review of current practice in Scotland
<p>Abstract</p> <p>Background</p> <p>Clopidogrel bisulfate is an antiplatelet agent used to prevent ischaemic events in patients with vascular disease. Current guidelines recommend withholding clopidogrel for 7 days pre-operatively. However these are not based on orthop...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-05-01
|
| Series: | Thrombosis Journal |
| Online Access: | http://www.thrombosisjournal.com/content/5/1/6 |